224 related articles for article (PubMed ID: 2661286)
1. Reciprocal allogeneic bone marrow transplantation between NOD mice and diabetes-nonsusceptible mice associated with transfer and prevention of autoimmune diabetes.
LaFace DM; Peck AB
Diabetes; 1989 Jul; 38(7):894-901. PubMed ID: 2661286
[TBL] [Abstract][Full Text] [Related]
2. Patterns of hemopoietic reconstitution in nonobese diabetic mice: dichotomy of allogeneic resistance versus competitive advantage of disease-resistant marrow.
Kaufman CL; Li H; Ildstad ST
J Immunol; 1997 Mar; 158(5):2435-42. PubMed ID: 9036994
[TBL] [Abstract][Full Text] [Related]
3. Expression of genetically determined diabetes and insulitis in the nonobese diabetic (NOD) mouse at the level of bone marrow-derived cells. Transfer of diabetes and insulitis to nondiabetic (NOD X B10) F1 mice with bone marrow cells from NOD mice.
Wicker LS; Miller BJ; Chai A; Terada M; Mullen Y
J Exp Med; 1988 Jun; 167(6):1801-10. PubMed ID: 3290380
[TBL] [Abstract][Full Text] [Related]
4. Mixed allogeneic chimerism induced by a sublethal approach prevents autoimmune diabetes and reverses insulitis in nonobese diabetic (NOD) mice.
Li H; Kaufman CL; Boggs SS; Johnson PC; Patrene KD; Ildstad ST
J Immunol; 1996 Jan; 156(1):380-8. PubMed ID: 8598488
[TBL] [Abstract][Full Text] [Related]
5. Analyses of development of insulitogenic T lymphocytes in NOD mice by transplantation of bone marrow, thymus, and pancreas.
Ida T; Yasumizu R; Ohnishi Y; Honxue F; Oyaizu N; Than S; Sugiura K; Inaba MM; Kuzuya H; Makino S
Transplantation; 1990 May; 49(5):976-82. PubMed ID: 2186525
[TBL] [Abstract][Full Text] [Related]
6. Allogeneic chimerism induces donor-specific tolerance to simultaneous islet allografts in nonobese diabetic mice.
Li H; Kaufman CL; Ildstad ST
Surgery; 1995 Aug; 118(2):192-7; discussion 197-8. PubMed ID: 7638733
[TBL] [Abstract][Full Text] [Related]
7. Transplantation analysis of B cell destruction in (NOD x CBA)F1 mouse bone marrow chimeras.
Serreze DV; Leiter EH; Shultz LD
Diabetologia; 1990 Feb; 33(2):84-92. PubMed ID: 2109714
[TBL] [Abstract][Full Text] [Related]
8. Prevention of type I diabetes in nonobese diabetic mice by allogenic bone marrow transplantation.
Ikehara S; Ohtsuki H; Good RA; Asamoto H; Nakamura T; Sekita K; Muso E; Tochino Y; Ida T; Kuzuya H
Proc Natl Acad Sci U S A; 1985 Nov; 82(22):7743-7. PubMed ID: 3906651
[TBL] [Abstract][Full Text] [Related]
9. Unusual resistance of ALR/Lt mouse beta cells to autoimmune destruction: role for beta cell-expressed resistance determinants.
Mathews CE; Graser RT; Savinov A; Serreze DV; Leiter EH
Proc Natl Acad Sci U S A; 2001 Jan; 98(1):235-40. PubMed ID: 11136257
[TBL] [Abstract][Full Text] [Related]
10. Hematopoietic mixed chimerism derived from allogeneic embryonic stem cells prevents autoimmune diabetes mellitus in NOD mice.
Verda L; Kim DA; Ikehara S; Statkute L; Bronesky D; Petrenko Y; Oyama Y; He X; Link C; Vahanian NN; Burt RK
Stem Cells; 2008 Feb; 26(2):381-6. PubMed ID: 17975228
[TBL] [Abstract][Full Text] [Related]
11. Treatment of systemic and organ-specific autoimmune disease in mice by allogeneic bone marrow transplantation.
Ikehara S; Nakamura T; Sekita K; Muso E; Yasumizu R; Ohtsuki H; Hamashima Y; Good RA
Prog Clin Biol Res; 1987; 229():131-46. PubMed ID: 3299389
[TBL] [Abstract][Full Text] [Related]
12. NOD marrow stem cells adoptively transfer diabetes to resistant (NOD x NON)F1 mice.
Serreze DV; Leiter EH; Worthen SM; Shultz LD
Diabetes; 1988 Feb; 37(2):252-5. PubMed ID: 3134263
[TBL] [Abstract][Full Text] [Related]
13. Absence of insulitis and overt diabetes in athymic nude mice with NOD genetic background.
Makino S; Harada M; Kishimoto Y; Hayashi Y
Jikken Dobutsu; 1986 Oct; 35(4):495-8. PubMed ID: 3542537
[TBL] [Abstract][Full Text] [Related]
14. Induction of diabetes in standard mice by immunization with the p277 peptide of a 60-kDa heat shock protein.
Elias D; Marcus H; Reshef T; Ablamunits V; Cohen IR
Eur J Immunol; 1995 Oct; 25(10):2851-7. PubMed ID: 7589082
[TBL] [Abstract][Full Text] [Related]
15. I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice.
Noorchashm H; Lieu YK; Noorchashm N; Rostami SY; Greeley SA; Schlachterman A; Song HK; Noto LE; Jevnikar AM; Barker CF; Naji A
J Immunol; 1999 Jul; 163(2):743-50. PubMed ID: 10395666
[TBL] [Abstract][Full Text] [Related]
16. Development of insulin-dependent diabetes mellitus in [(NOD + BALB/c) --> NOD] mixed allogeneic bone marrow chimeras.
Takao F; Yasumizu R; Than S; Ohnishi-Inoue Y; Sigiura K; Inaba M; Ikehara S
Immunobiology; 1995 Nov; 194(4-5):376-89. PubMed ID: 8749231
[TBL] [Abstract][Full Text] [Related]
17. Transfer of autoimmune diabetes from diabetic NOD mice to NOD athymic nude mice: the roles of T cell subsets in the pathogenesis.
Matsumoto M; Yagi H; Kunimoto K; Kawaguchi J; Makino S; Harada M
Cell Immunol; 1993 Apr; 148(1):189-97. PubMed ID: 8098666
[TBL] [Abstract][Full Text] [Related]
18. Abrogation of autoimmune diabetes in nonobese diabetic mice and protection against effector lymphocytes by transgenic paracrine TGF-beta1.
Moritani M; Yoshimoto K; Wong SF; Tanaka C; Yamaoka T; Sano T; Komagata Y; Miyazaki J; Kikutani H; Itakura M
J Clin Invest; 1998 Aug; 102(3):499-506. PubMed ID: 9691086
[TBL] [Abstract][Full Text] [Related]
19. Development of diabetogenic T cells from NOD/Lt marrow is blocked when an allo-H-2 haplotype is expressed on cells of hemopoietic origin, but not on thymic epithelium.
Serreze DV; Leiter EH
J Immunol; 1991 Aug; 147(4):1222-9. PubMed ID: 1869820
[TBL] [Abstract][Full Text] [Related]
20. Organ-specific and systemic autoimmune diseases originate from defects in hematopoietic stem cells.
Ikehara S; Kawamura M; Takao F; Inaba M; Yasumizu R; Than S; Hisha H; Sugiura K; Koide Y; Yoshida TO
Proc Natl Acad Sci U S A; 1990 Nov; 87(21):8341-4. PubMed ID: 2236044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
